Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17589904rdf:typepubmed:Citationlld:pubmed
pubmed-article:17589904lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:17589904lifeskim:mentionsumls-concept:C0239946lld:lifeskim
pubmed-article:17589904lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:17589904lifeskim:mentionsumls-concept:C0039350lld:lifeskim
pubmed-article:17589904lifeskim:mentionsumls-concept:C0002199lld:lifeskim
pubmed-article:17589904pubmed:issue23lld:pubmed
pubmed-article:17589904pubmed:dateCreated2007-6-25lld:pubmed
pubmed-article:17589904pubmed:abstractTextTo investigate the antifibrotic effects of peginterferon-alpha 2b and taurine on oxidative stress markers and hepatocellular apoptosis.lld:pubmed
pubmed-article:17589904pubmed:languageenglld:pubmed
pubmed-article:17589904pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:citationSubsetIMlld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17589904pubmed:statusMEDLINElld:pubmed
pubmed-article:17589904pubmed:monthJunlld:pubmed
pubmed-article:17589904pubmed:issn1007-9327lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:BozdayiMithat...lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:DeveciSalihSlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:MasMehmet...lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:ComertBilginBlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:MasNuketNlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:AkayCemalClld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:YurdaydinCiha...lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:BozkayaHakanHlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:UzunalimogluO...lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:SaidHarun MHMlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:TasciIlkerIlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:IsikAhmet...lld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:AlcigirGunayGlld:pubmed
pubmed-article:17589904pubmed:authorpubmed-author:VuralSevil...lld:pubmed
pubmed-article:17589904pubmed:issnTypePrintlld:pubmed
pubmed-article:17589904pubmed:day21lld:pubmed
pubmed-article:17589904pubmed:volume13lld:pubmed
pubmed-article:17589904pubmed:ownerNLMlld:pubmed
pubmed-article:17589904pubmed:authorsCompleteYlld:pubmed
pubmed-article:17589904pubmed:pagination3237-44lld:pubmed
pubmed-article:17589904pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:meshHeadingpubmed-meshheading:17589904...lld:pubmed
pubmed-article:17589904pubmed:year2007lld:pubmed
pubmed-article:17589904pubmed:articleTitlePegylated interferon-alpha plus taurine in treatment of rat liver fibrosis.lld:pubmed
pubmed-article:17589904pubmed:affiliationDepartment of Internal Medicine, Gulhane School of Medicine Etlik 06018 Ankara, Turkey. itasci@gata.edu.trlld:pubmed
pubmed-article:17589904pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17589904pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17589904lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17589904lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17589904lld:pubmed